Measuring severity of psoriasis: methodological issues

References

• Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238–44
   PubMedGoogle Scholar
• Aschheim E. Can psoriasis be quantitated?. Acta Derm Venereol (Stockh) 1969; 49: 72–5
   PubMed Web of Science ®Google Scholar
• Marks R. Measurement of drug effects in psoriasis. Retinoids Today Tomorrow 1994; 34: 11–14
   Google Scholar
• Marks R, Barton S P, Shuttleworth D, et al. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235–40
   PubMedGoogle Scholar
• Ramsey B, Lawrence C M. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991; 124: 565–70
   PubMed Web of Science ®Google Scholar
• DeVellis R F. Scale development: theory and applications. Sage Publications, Newbury Park 1991
   Google Scholar
• Hays R D, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Quality Life Res 1993; 2: 441–9
   PubMed Web of Science ®Google Scholar
• Aiken L R. Psychological testing and assessment. Allyn and Bacon, Boston 1979
   Google Scholar
• Shaughnessy J J, Zechmeister E B. Research methods in psychology. MaGraw-Hill, New York 1990
   Google Scholar
• Fleischer AB, Jr, Rapp S R, Reboussin D M, et al. Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol 1994; 102: 967–9
   PubMed Web of Science ®Google Scholar
• Baughman R D, Sobel R. Psoriasis: a measure of severity. Arch Dermatol 1970; 101: 390–5
   PubMedGoogle Scholar
• Camisa C. Psoriasis. Blackwell Scientific, Boston 1994
   Google Scholar
• McHenry P M, Dorherty V R. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127: 13–17
   PubMed Web of Science ®Google Scholar
• Cecchi R, Seghieri G, Gironi A, et al. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 1992; 185: 93–5
   PubMed Web of Science ®Google Scholar
• Duncan J I, Horrocks C, Ormerod A D, et al. Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy. Clin Exp Immunol 1991; 85: 93–6
   Web of Science ®Google Scholar
• Harland C C, Whitaker R P, Barron J L, et al. Increased urine neopterin levels in psoriasis. Br J Dermatol 1992; 127: 453–7
   PubMed Web of Science ®Google Scholar
• Bahmer F. The size of lesions, or point counting as a step toward the solution of the PASI problem. Arch Dermatol 1989; 125: 1282–3, letter
   PubMedGoogle Scholar
• Tiling-Grosse S, Rees J. Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 1993; 128: 69–74
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof P CM. On the limitations of the psoriasis area and severity index (PASI). Br J Dermatol 1992; 126: 205, letter
   PubMed Web of Science ®Google Scholar
• Lahti A, Kopola H, Harila A, et al. Assessment of skin erythema by eye, laser doppler flowmeter, spectro-radiometer, two-channel erythema meter and Minolta chroma meter. Arch Dermatol Res 1993; 285: 278–82
   PubMed Web of Science ®Google Scholar
• Quinn A G, McLelland J, Essex T. Quantification of contact allergic inflammation: a comparison of existing methods with a scanning laser doppler velocimeter. Acta Derm Venereol (Stockh) 1993; 73: 21–5
   PubMed Web of Science ®Google Scholar
• Bakhtan S, Pershing L K, Poncelet C E, et al. Objective noninvasive and subjective visual assessments of psoriasis and their use in bioequivalence testing of topical 0.05% betamethasone diproprionate. J Invest Dermatol 1993; 100: 540, abstract
   Web of Science ®Google Scholar
• Gupta M A, Gupta A K, Ellis C N, et al. Some psychosomatic aspects of psoriasis. Adv Dermatol 1990; 5: 21–32
   PubMedGoogle Scholar
• Hardy G E, Cotterill J A. A study of depression and obsessionality in dysmorphophobic and psoriatic patients. Br J Psychiatry 1982; 140: 19–22
   PubMed Web of Science ®Google Scholar
• Leichtman S R, Burnett J W, Robinson HM, Jr. Body image concerns of psoriasis patients as reflected in human figure drawings. J Personality Assessment 1981; 45: 478–84
   PubMed Web of Science ®Google Scholar
• Ramsey B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195–201
   PubMed Web of Science ®Google Scholar
• Finlay A Y, Khan G K, Luscombe D K, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123: 751–6
   PubMed Web of Science ®Google Scholar
• Ghiselli E E, Campbell J P, Zedeck S. Measurement theory for the behavioral sciences. Freeman, San Francisco 1981
   Google Scholar
• Martin P, Bateson P. Measuring behavior: an introductory guide. Cambridge University Press, New York 1986
   Google Scholar
• Nunnally J C. Psychometric theory. McGraw-Hill, New York 1978
   Google Scholar